EP3119423
TREATMENT OF CANCER USING CHIMERIC ANTIGEN RECEPTOR
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
13.3.2015EP published:
14.12.2022EP application number:
15712503.0
EPO information:
European Patent Register
Max expiry date:
12.3.2035
Title in English:
TREATMENT OF CANCER USING CHIMERIC ANTIGEN RECEPTORLanguage of the patent:
English
Timeline
Today
13.3.2015EP application
14.12.2022EP Publication
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Name:
The Trustees of The University of PennsylvaniaAddress:
3600 Civic Center Boulevard, 9th Floor, Philadelphia, PA 19104, US
Inventor
Name:
LOEW, AndreasAddress:
Cambridge, MA 02139, US
Name:
MILONE, Michael C.Address:
Cherry Hill, NJ 08002, US
Name:
POWELL, Daniel J.Address:
Bala Cynwyd, PA 19004, US
Name:
ZHAO, YangbingAddress:
Lumberton, NJ 08048, US
Priority
Number:
201461953783 PDate:
15.3.2014Country:
US
Number:
201461976375 PDate:
7.4.2014Country:
US
Number:
201462027154 PDate:
21.7.2014Country:
US
Number:
201462076146 PDate:
6.11.2014Country:
US
Number:
201462097286 PDate:
29.12.2014Country:
US
Classification
Categories:
A61K 39/00, A61K 39/12, A61K 39/395, C07K 14/725, C07K 14/705, C07K 16/28, C07K 16/32, C12N 5/0783, A61P 35/00, C07K 16/30, A61K 39/39, A61P 35/02